#160 - Integrated Workflow for Investigating Suspected Dili Associated With Adulterated Herbal and Dietary Products
Year: 2026
Type: article
Abstract: Introduction and Objectives Drug- and herb-induced liver injury (DILI/HILI) associated with irregular or adulterated supplements represents a major diagnostic challenge due to uncertain composition and the frequent presence of undeclared pharmacologically active substances. AIM: To describe an integrated translational protocol for investigating hepatotoxicity associated with herbal products, dietary supplements, or adulterated formulations by combining clinical assessment, chemical characterization, and toxicological screening. Materials and Methods An observational protocol was developed integrating structured clinical evaluation, exclusion of alternative etiologies, and causality assessment using the updated RUCAM. Analytical characterization of suspected products was performed using gas chromatography–mass spectrometry (GC–MS), inductively coupled plasma optical emission spectrometry (ICP–OES), and UV–Vis spectrophotometric analyses for phytochemical and antioxidant evaluation. Preliminary biological toxicity was assessed using the Artemia salina lethality bioassay. The protocol was validated in a clinical case of acute liver injury associated with the consumption of an irregular weight-loss product. Results The protocol enabled consistent integration of clinical, toxicological, and analytical findings. The validated case demonstrated an acute hepatocellular injury pattern classified as “probable” according to the updated RUCAM. GC–MS analysis identified multiple undeclared synthetic adulterants, including sibutramine, fluoxetine, bupropion, diazepam, and bisacodyl. ICP–OES analysis demonstrated discrepancies between labeled and detected elemental composition. The Artemia salina bioassay revealed marked biological toxicity (LC50 = 120.8 ppm), compatible with the presence of pharmacologically active adulterants. Conclusions The proposed protocol provides a reproducible translational workflow for investigating hepatotoxicity associated with complex or adulterated products, strengthening causal inference through the integration of clinical evaluation, analytical chemistry, and experimental toxicology
Source: Annals of Hepatology
Authors: Genario Santos, Ferdinando Góis, Vinícius Nunes, Simone Cunha, Maria Schinoni, Raymundo Parana, Ademir Do Vale
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,500
OpenAlex ID: W7204245160
